腹膜透析療法Q&A

出版社： 東京医学社
著者：
発行日： 2014-09-10
分野： 臨床医学：内科  >  腎臓
ISBN： 9784885632389
電子書籍版： 2014-09-10 （第1版第2刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

4,400 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

4,400 円(税込)

購入する

目次

  • 腹膜透析療法Q&A

    ―目次―

    医師編
    　腎代替療法の説明の仕方を教えてください
    　腹膜透析の原理と透析量の評価方法を教えてください
    　腹膜透析の治療モードの選び方を教えてください
    　腹膜透析患者の貧血治療について教えてください
    　腹膜透析患者の栄養管理について教えてください
    　腹膜透析患者の糖尿病管理について教えてください
    　ほか

    看護師・PDコーディネーター編
    　保存期の療法選択外来の取り組みについて教えてください
    　PD教育プログラム作成のポイントについて教えてください
    　PDコーディネーターの役割を具体的に教えてください
    　在宅療法推進のための連携について教えてください
    　透析患者が高齢化するわが国では、今後どのような
    　　治療体制が必要となりますか？
    　家庭状況や仕事に関する疑問集

    保険制度編
    　腹膜透析にかかわる医療制度についての疑問集

    新しいPDの挑戦
    　PDは慢性心不全の治療として有用ですか？
    　　また、その有用性に関する臨床エビデンスはあるのですか？
    　往診医療とPDについて教えてください
    　災害時のPDの対応について教えてください
    　スマートフォンを用いた遠隔地からのPD診療支援システムに
    　　ついて教えてください
    　腹膜透析患者が海外に出ていくには
    　　どのようにしたらよいですか？

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

医師編

P.16 掲載の参考文献
1) 日本腎臓学会・日本透析医学会・日本移植学会・日本臨床腎移植学会編 : 腎不全 治療選択とその実際 2012年度版, 2012
 
2) 日本腎臓学会編 : CKD診療ガイド 2012. 日腎会誌 54 : 1031-1189, 2012
 
3) 川口良人, 二瓶宏, 平沢由平, 他 : 透析導入ガイドラインの作成に関する研究. 平成3年度厚生科学研究 : 腎不全医療研究事業報告書 (班長 : 三村信英), 国立佐倉病院, pp125-132, 1992
 
4) 2009年度版日本透析医学会腹膜透析ガイドライン. 透析会誌 42 : 285-315, 2009
 
5) 日本透析医学会 : 図説わが国の慢性透析療法の現況2013年12月31日現在, 2014
 
6) Kawanishi H, Kawaguchi Y, Fukui H, et al : Encapsulating peritoneal sclerosis in Japan : a prospective, controlled, multicenter study. Am J Kidney Dis 44 : 729-737, 2004
PubMed
P.24 掲載の参考文献
1) Ganter G : Veber die Beseitingung giftinger stoffe aus dem Blute durch Dialyse. Munchener Medizische Wochemshrift 70 : 1478-1480, 1923
 
2) Fine J, Frank H, Seligman AM : The treatment of acute renal failure by peritoneal irrigation. Ann Surg 124 : 857-875, 1946
 
3) Kolff WJ, Berk HT : The artificial kidney : a dialyzer with a great area. Acta Med Scand 117 : 121-134, 1944
 
4) Popovich RP, Moncrief JW, Dechard JF, et al : The definition of a novel portable/wearable equilibrium peritoneal dialysis technique. Abstr Am Soc Artif Intern Organs 5 : 64, 1976
 
5) Twardowski ZJ, Nolph KD, Prowant BF, et al : Peritoneal equilibration test. Perit Dial Bull 7 : 138-147, 1987
 
6) 山下明泰, 濱田浩幸 : 腹膜透過能の新しい簡易評価式の導出. 透析会誌 31 : 183-189, 1998
 
7) 山下明泰 : よくわかる腹膜透析の基礎, 東京医学社, 東京, 1998
 
8) Henderson LW, Nolph KD : Altered permeability of the peritoneal membrane after using hypertonic peritoneal dialysis fluid. J Clin Invest 48 : 992-1000, 1969
PubMed
9) Babb AL, Johansen PJ, Strand MJ, et al : Bi-directional permeability of the human peritoneum to middle molecules. Proc Eur Dial Transplant Assoc 10 : 247-262, 1973
PubMed
10) Garred LJ, Canaud B, Farell PC : A simple kinetic model for assessing peritoneal mass transfer in chronic continuous ambulatory peritoneal dialysis. Am Soc Artif Intern Organs J 6 : 131-137, 1983
 
11) CANADA-USA (CANUSA) peritoneal dialysis study group : Adequacy of dialysis and nutrition in continuous peritoneal dialysis : Association with clinical outcomes. J Am Soc Nephrol 7 : 198-207, 1996
 
12) NKF-DOQI : Clinical practice guidelines for peritoneal dialysis adequacy. Am J Kidney Dis 30 : S69-S136, 1997
 
13) Lo WK, Ho YW, Li CS, et al : Effect of Kt/V on survival and clinical outcome in CAPD patients in a randomized prospective study. Kidney Int 64 : 649-656, 2003
 
14) 中山昌明, 川西秀樹, 友雅司, 他 : 2009年版日本透析医学会「腹膜透析ガイドライン」. 透析会誌 42 : 285-315, 2009
 
15) Blake P : A review of the DOQI recommendations for peritoneal dialysis. Perit Dial Int 18 : 247-251, 1998
 
16) Lowrie EG, Huang WH, Lew NI : Death risk predictors among peritoneal dialysis and hemodialysis patients : a preliminary comparison. Am J Kidney Dis 26 : 220-228, 1995
 
17) Yamashita A, Ishizaki M, Nakamoto M, et al : Re-evaluation of adequate dose in Japanese PD patients. Adv in Perit Dial 19 : 254-258, 2003
 
P.34 掲載の参考文献
1) 中元秀友 : 腹膜透析. 透析療法合同専門委員会企画・編 : 血液浄化療法ハンドブック 改訂第6版, pp150-170, 協同医書出版社, 東京, 2011
 
2) 中元秀友 : 腹膜透析療法. 篠田俊雄, 峰島三千男編 : 透析のすべて-原理, 技術, 臨床- (Clinical Engineering), pp170-180, 秀潤社, 東京, 2011
 
P.46 掲載の参考文献
1) 中尾俊之, 他 : 慢性透析患者の食事療法基準. 透析会誌 47 : 287-291, 2014
 
2) 中山昌明, 他 : 2009年版日本透析医学会「腹膜透析ガイドライン」. 透析会誌 42 : 285-315, 2009
 
P.53 掲載の参考文献
1) 中尾俊之, 他 : CAPDおよびAPDにおける腹膜ブドウ糖吸収量の検討. 腎と透析別冊 腹膜透析 98 : 196-198, 1998
 
2) Skubala A, et al : Continuous glucose monitoring system in 72-hour glucose profile assessment in patients with end-stage renal disease on maintenance continuous ambulatory peritoneal dialysis. Med Sci Monit 16 : 75-83, 2010
 
3) Marshall J, et al : Glycemic control in diabetic CAPD patients assessed by continuous glucose monitoring system (CGMS). Kidney Int 64 : 1480-1486, 2003
PubMed
4) Holmes C, Mujais S : Glucose sparing in peritoneal dialysis : Implications and metrics. Kidney Int 70 : S104-S109, 2006
 
5) 日本透析医学会 : 2009年版日本透析医学会「腹膜透析ガイドライン」. 透析会誌 42 : 285-315, 2009
 
6) 阿部雅紀 : 血糖をどうコントロールする? 海津嘉蔵編 : あなたも名医! 透析まで行かせない! CKD診療, pp118-127, 日本医事新報社, 東京, 2013
 
7) 日本透析医学会 : 血液透析患者の糖尿病治療ガイド 2012. 透析会誌 46 : 311-357, 2013
 
8) Freedman BI, Shenoy RN, Planer JA, et al : Comparison of glycated albumin and hemoglobin A1c concentrations in diabetic subjects on peritoneal and hemodialysis. Perit Dial Int 30 : 72-79, 2010
PubMed
9) Duong U, et al : Glycemic control and survival in peritoneal dialysis patients with diabetes mellitus. Clin J Am Soc Nephrol 6 : 1041-1048, 2011
PubMed
P.64 掲載の参考文献
1) Gheorghiade M, et al : Relationship between admission serum sodium and clinical outcomes in patients hospitalized for heart failure : an analysis from the OPTIMIZE-HF registry. Eur Heart J 28 (8) : 980-988, 2007
PubMed
2) Anderson RJ, et al : Hyponatremia : a prospective analysis of its epidemiology and the pathogenetic role of vasopressinm. Ann Intern Med 102 (2) : 164-168, 1985
PubMed
3) Zevallos G, et al : Hyponatremia in patients undergoing CAPD : role of water gain and/or malnutrition. Perit Dial Int 21 (1) : 72-76, 2001
 
4) Edelman IS, et al : Interrelations between serum sodium concentration, serum osmolarity and total exchangeable sodium, total exchangeable potassium and total bodywater. J Clin Invest 37 : 1236-1256, 1958
 
5) Brenner & Rector's The Kidney, 8th ed, pp459-504, Saunders, Philadelphia, 2008
 
6) Nolph KD, et al : Autoregulation of sodium and potassium removal during continuous ambulatory peritoneal dialysis. Trans Am Soc Artif Intern Organs 26 : 334-338, 1980
PubMed
7) Nakayama M, et al : Anti-hypertensive effect of low Na connection (120 mEq/L) solution for CAPD patients. Clin Nephrol 41 : 357-363, 1994
 
8) Seldin and Giebisch's The Kidney 5th ed, pp1511-1540, Academic Press, London, 2013
 
9) Dimitriandis C, et al : Hyponatremia in peritoneal dialysis : epidemiology in a single center and correlation with clinical and biochemical parameters. PD 34 (3) : 260-270, 2014
 
10) Kim S : Hyponatremia and hypokalemia in PD patients. Progress in PD, pp145-156, InTech 2011
 
11) Cherney DZ, et al : A physiological analysis of hyponatremia : implications for patients on peritoneal dialysis. Perit Dial Int 21 (1) : 7-13, 2001
PubMed
12) Wright M, et al : Polydipsia : a feature of peritoneal dialysis. Nephrol Dial Transplant 19 : 1581-1586, 2004
 
13) Zanger R : Hyponatremia and hypokalemia in patients on peritoneal dialysis. Semin Dial 23 (6) : 575-580, 2010
 
14) Lindholm B, et al : Muscle water and electrolytes in patients undergoing continuous ambulatory peritoneal dialysis. Acta Med Scand 219 (3) : 323-330, 1986
PubMed
15) Nolph KD, et al : Autoregulation of sodium and potassium removal during continuous ambulatory peritoneal dialysis. Trans am Soc Artif Inern Organs 26 : 334-338, 1980
PubMed
16) Brown ST, et al : Potassium removal with peritoneal dialysis. Kidney Int 4 (1) : 67-69, 1973
PubMed
17) Mathialahan T, et al : Enhanced large intestinal potassium permeability in end-stage renal disease. J Pathol 206 : 46-51, 2005
PubMed
18) Lee HH, et al : De novo hyponatremia in patients undergoing peritoneal dialysis : a 12-month observational study. Korean J Nephrol 29 : 31-37, 2010
 
19) Shu KH, et al : Intestinal bacterial overgrowth in CAPD patients with hypokalemia. Nephrol Dial Transplant 24 (4) : 1289-1292, 2009
PubMed
20) Daugirdas JT, et al : Handbook of dialysis 4th ed, pp446-454, Lippincott Williams & Wilkins, Philadelphia, 2007
 
21) Wei M, et al : Relationship between serum magnesium, parathyroid hormone, and vascular calcification in patients on dialysis : a literature review. Perit Dial Int 26 (3) : 366-373, 2006
PubMed
P.73 掲載の参考文献
1) 日本透析医学会 : 慢性腎臓病に伴う骨・ミネラル代謝異常の診療ガイドライン. 透析会誌 45 : 301-356, 2012
 
2) Shigematsu T, Nakashima Y, Ohya M, et al : The management of hyperphosphatemia by lanthanum carbonate in chronic kid ney disease patients. Int J Nephrol Renovasc Dis 5 : 81-89, 2012
 
3) Noordzij M, Korevaar JC, Bos WJ, et al : Mineral metabolism and cardiovascular morbidity and mortality risk : peritoneal dialysis patients compared with haemodialysis patients. Nephrol Dial Transplant 21 : 2513-2520, 2006
PubMed
4) Sherrard DJ, Hercz G, Pei Y, et al : The spectrum of bone disease in end-stage renal failure-An evolving disorder. Kidney Int 43 : 436-442, 1993
PubMed
5) Armstrong A, Beer J, Noonan K, et al : Reduced calcium dialysate in CAPD patients : efficacy and limitations. Nephrol Dial Transplant 12 : 1223-1228, 1997
PubMed
6) Yamamoto H, Kasai K, Hamada C, et al ; Japan Peritoneal Dialysis-Mineral Bone Disorders (PD-MBD) Research Group : Differences in corrective mode for divalent ions and parathyroid hormone between standard- and low-calcium dialysate in patients on continuous ambulatory peritoneal dialysis-result of a nationwide survey in Japan. Perit Dial Int 28 (Suppl 3) : S128-130, 2008
 
7) Lee YK, Choi HY, Shin SK, et al : Effect of lanthanum carbonate on phosphate control in continuoius ambulatory peritoneal dialysis patients in Korea : a randomized prospective study. Cli Nephrol 79 : 136-142, 2012
 
8) Hutchison A, Gill M, Copley JB, et al : Lanthanum carbonate versus placebo for management of hyperphosphatemia in patients undergoing peritoneal dialysis : a subgroup analysis of a phase 2 radomized contolled study of dialysis patients. BMC Nephrol 14 : 40, 2013
 
9) Ohno M, Ohashi H, Oda H, et al : Lanthanum carbonate for hyperphosphatemia in patients on peritoneal dialysis. Perit Dial Int 33 : 297-303, 2013
PubMed
10) Lindberg JS, Culleton B, Wong G, et al : Cinacalcet HCL, an oral Calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis : a randomized, double-blind, multicenter study. J Am Soc Nephrol 16 : 800-807, 2005
PubMed
P.81 掲載の参考文献
1) Bianchi P, Buoncristiani E, Buoncristiani U : Antisepsis. Contrib Nephrol 154 : 1-6, 2007
PubMed
2) Williams VR, Quinn R, Callery S, et al : The impact of treatment modality on infection-related hospitalization rates in peritoneal dialysis and hemodialysis patients. Perit Dial Int 31 : 440-449, 2011
PubMed
3) Campos RP, Chula DC, Riella MC : Complications of the perito neal access and their management. Contrib Nephrol 163 : 183-197, 2009
 
4) Gould IM, Casewell MW : The laboratory diagnosis of peritonitis during continuous ambulatory peritoneal dialysis. J Hosp Infect 7 : 155-160, 1986
PubMed
5) Li PK, Szeto CC, Piraino B, et al : Peritoneal dialysis-related infections recommendations : 2010 update. Perit Dial Int 30 : 393-423, 2010
PubMed
6) Nakao M, Yokoyama K, Yamamoto I, et al : Risk factors for encapsulating peritoneal sclerosis in long-term peritoneal dialysis : a retrospective observational study. Ther Apher Dial 18 (1) : 68-73, 2014
PubMed
7) Kofteridis DP, Valachis A, Perakis K, et al : Peritoneal dialysis-associated peritonitis : clinical features and predictors of outcome. Int J Infect Dis 14 : e489-e493, 2010
PubMed
8) Li PK, Szeto CC, Piraino B, et al : Peritoneal dialysis-related infections recommendations : 2010 update. Perit Dial Int 30 : 393-423, 2010
PubMed
9) Fried LF, Bernardini J, Johnston JR, et al : Peritonitis influences mortality in peritoneal dialysis patients. J Am Soc Nephrol 7 : 2176-2182, 1006
 
10) Pajek J, Gucek A, Kloberne A, et al : Severe peritonitis in patients treated with peritoneal dialysis : a case series study. Ther Apheresis Dial 15 : 250-256, 2011
 
11) Davies S : Clinical practice guidelines module 3b : peritoneal dialysis. UK Renal Association, 3rd Edition, 2006
 
12) Brown MC, Simpson K, Kerssens JJ, et al : Scottish Renal Registry : Peritoneal dialysis-associated peritonitis rates and outcomes in a national cohort are not improving in the postmillennium (200-2007). Perit Dial Int 31 : 639-650, 2011
 
13) Ghali J, Bannister KM, Brown FG, et al : Microbiology and outcomes of peritonitis in Australian peritoneal dialysis patients. Perit Dial Int 31 : 651-662, 2011
PubMed
14) Mizuno M, Ito Y, Tanaka A, et al : Peritonitis is still an important factor for withdrawal from peritoneal dialysis therapy in the Tokai area of Japan. Clin Exp Nephrol 5 : 727-737, 2011
PubMed
15) Tan SH, Huang XH, Chan YH, et al : A prospective comparison of peritonitis between two disconnect CAPD systems in a single centre. Nephrology 10 : A69-A70, 2005
 
16) Li PK, Law MC, Chow KM, et al : Comparison of clinical outcome and ease of handling in two double-bag systems in continuous ambulatory peritonel dialysis : a prospective, randomized, controlled, multicenter study. Am J Kidney Dis 40 : 373-380, 2002
 
17) Han SH, Lee SC, Ahn SV, et al : Improving outcome of CAPD : twenty-five years' experience in a single Korean center. Perit Dial Int 27 : 432-440, 2007
 
18) Williams P, Swift S, Modun B : Continuous ambulatory peritoneal dialysis-associated peritonitis as a model device-related infection : phenotypic adaptation, the staphylococcal cell envelope and infection. J Hosp Infect 30 (Suppl) : 35-43, 1995
 
19) Segal JH, Messana JM : Prevention of peritonitis in peritoneal dialysis. Semin Dial 26 (4) : 494-502, 2013
PubMed
20) Nishina M, Yanagi H, Kakuta T, et al : A 10-year retrospective cohort study on the risk factors for peritoneal dialysis-related peritonitis : a single-center study at Tokai University Hospital. Clin Exp Nephrol, 2013 Oct 2.
PubMed
21) 今田聰雄 : CAPD関連腹膜炎・出口部感染の20年の軌跡と最新情報. 腎と透析 61 別冊腹膜透析 2006 : 558-561, 2006
 
22) Piraino B, Bernardini J, Brown E, et al : ISPD position statement on reducing the risks of peritoneal dialysis-related infections. Perit Dial Int 31 : 614-630, 2011
PubMed
23) Yang Z, Xu R, Zhuo M, et al : Advanced nursing experience is beneficial for lowering the peritonitis rate in patients on peritoneal dialysis. Perit Dial Int 32 : 60-66, 2012
 
24) Hall G, Bogan A, Dreis S, et al : New directions in peritoneal dialysis patient training. Nephrol Nurs J 31 : 149-154, 159-163, 2004
 
25) Di Bonaventura G, Cerasoli P, Pompillo Arrizza F, et al : In vitro microbiology studies on a new peritoneal dialysis connector. Perit Dial Intern 32 (5) : 552-557, 2012
 
26) Sharma SK, Chaurasia RK, Sijapati MJ, et al : Peritonitis in continuous ambulatory peritoneal dialysis. JNMA J Nepal Med Assoc 49 : 104-107, 2010
PubMed
27) Niu HX, Tang X, Zhou WD, et al : Frequent peritoneal dialysis-related peritonitis : clinical characteristics, risk factors and treatments. Nan Fang Yi Ke Da Xue Xue Bao 30 : 855-858, 2010
PubMed
28) Lobo JV, Villar KR, de Andrade Junior MP, et al : Predictor factors of peritoneal dialysis-related peritonitis. J Bras Nefrol 32 : 156-164, 2010
PubMed
29) Yip T, Tse KC, Lam MF, et al : Colonic diverticulosis as a risk factor for peritonitis in Chinese peritoneal dialysis patients. Perit Dial Int 30 : 187-191, 2010
PubMed
30) Yip T, Tse KC, Lam MF, et al : Risks and outcomes of peritonitis after flexible colonoscopy in CAPD patients. Perit Dial Int 27 : 560-564, 2007
PubMed
31) Chuang YW, Shu KH, Yu TM, et al : Hypokalaemia : an independent risk factor of Eneterobacteriaceae peritonitis in CAPD patients. Nephrol Dial Transplant 24 : 1603-1608, 2009
 
32) Vijt D, Castro MJ, Endall G, et al : Post insertion catheter care in peritoneal dialysis (PD) centres across Europe-Part 2 : complication rates and individual patient outcomes. EDTNA ERCA J 30 : 91-96, 2004
PubMed
33) Nessim SJ, Bargman JM, Jassal SV : Relationship between double-cuff versus single-cuff peritoneal dialysis catheters and risk of peritonitis. Nephrol Dial Transplant 25 : 2310-2314, 2010
PubMed
34) Korzets Z, Erdberg A, Golan E, et al : Frequent involvement of the internal cuff segment in CAPD peritonitis and exit-site infection-an ultrasound study. Nephrol Dial Transplant 11 : 336-339, 1996
PubMed
35) Macchini F, Valade A, Ardissino G, et al : Chronic peritoneal dialysis in children : catheter related complications. A single centre experience. Pediatr Surg Int 22 : 524-528, 2006
PubMed
36) Piraino B : Today's approaches to prevent peritonitis. Contrib Nephrol 178 : 246-250, 2012
PubMed
37) Akoh JA : Peritoneal dialysis associated infections : An update on diagnosis and management. World. J Nephrol 1 (4) : 106-122, 2012
 
P.96 掲載の参考文献
1) Mangram AJ, et al : Guideline for prevention of surgical site infection. Infect Control Hosp Epidemil 20 : 247-278, 1999
 
2) 深澤瑞也, 松下和通, 神家満学, 他 : 新規挿入時に行う腹膜透析カテーテルの腹壁固定術 (New PWAT) PDカテーテル位置異常予防法. 透析会誌 39 : 235-252, 2006
 
3) 窪田実 : カテーテル位置異常への対処を教えてください. 腎と透析 64 : 825-827, 2008
 
P.103 掲載の参考文献
1) 野本保夫, 川口良人, 酒井信治, 他 : 硬化性被嚢性腹膜炎 (SEP) 診断・治療指針 (案) -1997年における改訂-. 透析会誌 31 : 303-311, 1998
 
2) 川西秀樹, 新宅究典, 森石みさき, 他 : 硬化性被嚢性腹膜炎 (SEP) に対する治療戦略 : 開腹・癒着剥離術の有効性. 腎と透析 46 別冊腎不全外科 99 : 84-87, 1999
 
3) Kawanishi H, Harada Y, Sakikubo E, et al : Successful surgical treatment for sclerosing encapsulating peritonitis. Advances in Peritoneal Dialysis 16 : 252-256, 2000
 
4) 川西秀樹 : 被嚢性腹膜硬化症に対する外科手術. 臨牀透析増刊号「透析患者の手術」19 : 991-998, 2003
 
5) 川西秀樹 : 腹膜透析における被?性腹膜硬化症 (EPS) は克服できるか. 臨牀透析 20 : 837-841, 2004
 
6) 室谷典義, 堀誠司, 佐藤純彦, 他 : 被?性腹膜硬化症 (EPS) の外科的治療. 腎と透析 61 別冊アクセス 2006 : 30-33, 2006
 
7) 堀誠司, 室谷典義 : CAPDの進歩と限界へのチャレンジ-外科治療. 腎と透析 69 : 67-69, 2010
 
P.108 掲載の参考文献
1) Matsuo N, Yokoyama K, Maruyama Y, et al : Clinical impact of a combined therapy of peritoneal dialysis and hemodialysis. Clin Nephrol 74 : 209, 2010
PubMed
2) Cheung AK, Rocco MV, Yan G, et al : Serum β-2 Microglobulin Levels Predict Mortality in Dialysis Patients : Result of the HEMO Study. J Am Soc Nephrol 17 : 546-555, 2006
 
3) Yokoyama K, Yoshida H, Matsuo N, et al : Serum beta2 microglobulin (beta2 MG) level is a potential predictor for encapsulating peritoneal sclerosis (EPS) in peritoneal dialysis patients. Clin Nephrol 69 (2) : 121-126, 2008
PubMed
P.116 掲載の参考文献
1) 日本透析医学会編 : 腹膜透析ガイドライン (2009年版). 透析会誌 42 : 285-315, 2009
 
2) CANADA-USA (CANUSA) peritoneal dialysis study group : Adequacy of dialysis and nutrition in continuous peritoneal dialysis : Association with clinical outcomes. J Am Soc Nephrol 7 : 198-207, 1996
 
3) Li PK, Chow KM, Wong TY, et al : Effects of an angiotensin-converting enzyme inhibitor on residual renal function in patients receiving peritoneal dialysis. A randomized, controlled study. Ann Intern Med 139 : 105-112, 2003
PubMed
4) Suzuki H, Kanno Y, Sugahara S, et al : Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD. Am J Kidney Dis 43 : 1056-1064, 2003
 
5) Brown EA, Davies SJ, Rutherford P, et al ; EAPOS Group : Survival of functionally anuric patients on automated peritoneal dialysis : The European APD Outcome Study. J Am Soc Nephrol 14 : 2948-2957, 2003
PubMed
6) Cheng L, Tang W, Wang T : Strong association between volume status and nutritional status in peritoneal dialysis patients. Am J Kidney Dis 45 : 891-902, 2005
PubMed
7) 野本保夫, 川口良人, 酒井信治, 他 : 硬化性被嚢性腹膜炎 (sclerosing encapsulating peritonitis, SEP) 診断・治療指針 (案) 1996年における改訂. 日透医会誌 30 : 1013-1022, 1997
 
8) Kawanishi H, Kawaguchi Y, Fukui H, et al : Encapsulating peritoneal sclerosis in Japan : a prospective, controlled, multicenter study. Am J Kidney Dis 44 : 729-737, 2004
PubMed
9) Yamamoto T, Nagasue K, Okuno S, et al : The role of peritoneal lavage and the prognostic significance of mesothelial cell area in preventing encapsulating peritoneal sclerosis. Perit Dial Int 30 : 343-352, 2010
PubMed
10) Johnson DW, Cho Y, Livingston BE, et al : Encapsulating peritoneal sclerosis : incidence, predictors, and outcomes. Kidney Int 77 : 904-912, 2010
PubMed
11) Garosi G, Oreopoulos DG : No need for an "expiry date" in chronic peritoneal dialysis to prevent encapsulating peritoneal sclerosis. Int Urol Nephrol 41 : 903-907, 2009
PubMed
12) Nakayama M, Miyasaki M, Honda K, et al : Encapsulating peritoneal sclerosis in the era of a multi-disciplinary approach based on biocompatible solutions : The Next-PD Study. Perit Dial Int, 2014 [Epub ahead of print]
 
13) Pecoits-Filho R, et al : Chronic inflammation in peritoneal dialysis : the search for the holy grail? Perit Dial Int 24 : 327-339, 2004
PubMed
14) Sampimon DE, Korte MR, Barreto DL, et al : Early diagnostic markers for encapsulating peritoneal sclerosis : a case-control study. Perit Dial Int 30 (2) : 163-169, 2010
PubMed
15) Ho-dac-Pannekeet MM, Hiralall JK, Struijk DG, et al : Longitudinal follow-up of CA125 in peritoneal effluent. Kidney Int 51 : 888-893, 1997
PubMed
16) Moriishi M, Kawanishi H : Fibrin degradation products are a useful marker for the risk of encapsulating peritoneal sclerosis. Adv Perit Dial 24 : 56-59, 2008
PubMed
17) Hirahara I, Inoue M, Umino T, et al : Matrix metalloproteinase levels in the drained dialysate reflect the peritoneal solute transport rate : a multicentre study in Japan. Nephrol Dial Transplant 26 : 1695-1701, 2011
 
18) Zweers MM, Struijk DG, Smit W, et al : Vascular endothelial growth factor in peritoneal dialysis : a longitudinal follow-up. J Lab Clin Med 137 : 125-132, 2001
PubMed
19) Pecoits-Filho R, Araujo MR, Lindholm B, et al : Plasma and dialysate IL-6 and VEGF concentrations are associated with high peritoneal solute transport rate. Nephrol Dial Transplant 17 : 1480-1486, 2002
PubMed
P.126 掲載の参考文献
1) Snyder JJ, et al : A comparison of transplant outcomes in peritoneal and hemodialysis patients. Kidney Int 62 : 1423-1430, 2002
PubMed
2) Yoo SW, et al : Preemptive living-donor renal transplantation : outcome and clinical advantages. Transplant Proc 41 : 117-120, 2009
PubMed
3) 佐藤滋 : PDと腎移植. 腎と透析 61 : 558-562, 2006
 
4) 小板橋賢一郎, 他 : Dialysis modalityが腎移植に与える影響. 腎と透析 71 : 287-288, 2011
 
5) 石橋道男, 他 : 生体腎および献腎移植の成績におよぼす透析期間の検討. 移植 47 : 205-218, 2012
Medical*Online
6) Perl J, et al : Impact of dialysis modality on survival after kidney transplant failure. Clin J Am Soc Nephrol 6 : 582-590, 2011
PubMed
7) Sofue T, et al : Excess fluid distribution affects tacrolimus absorption in peritoneal dialysis patients. Clin Exp Nephrol 17 (5) : 743-749, 2013
PubMed

新しいPDの挑戦

P.192 掲載の参考文献
1) Ronco C, Haapio M, House AA, et al : Cardiorenal syndrome. J Am Coll Cardiol 52 : 1527-1539, 2008
PubMed
2) Jessup M, Brozena S : Heart failure. N Engl J Med 348 : 2007-2018, 2003
PubMed
3) Nakayama M : Nonuremic indication for peritoneal dialysis for refractory heart failure in cardiorenal syndrome type II : review and perspective. Perit Dial Int 33 : 8-14, 2013
PubMed
4) Nakayama M, Nakano H, Nakayama M : Novel therapeutic option for refractory heart failure in elderly patients with chronic kidney disease by incremental peritoneal dialysis. J Cardiol 55 : 49-54, 2010
PubMed
5) Sanchez JE, Ortega T, Rodriguez C, et al : Efficacy of peritoneal ultrafiltration in the treatment of refractory congestive heart failure. Nephrol Dial Transplant 25 : 605-610, 2010
PubMed

書評

最近チェックした商品履歴

Loading...